{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:17:57Z","timestamp":1773152277890,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11934-010-0128-2","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T04:40:12Z","timestamp":1276058412000},"page":"310-314","source":"Crossref","is-referenced-by-count":27,"title":["Contrasting the Percutaneous Nerve Evaluation Versus Staged Implantation in Sacral Neuromodulation"],"prefix":"10.1007","volume":"11","author":[{"given":"Chad","family":"Baxter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja-Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"128_CR1","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","volume":"178","author":"PE Kerrebroeck van","year":"2007","unstructured":"van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al.: Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 2007, 178:2029\u20132034.","journal-title":"J Urol"},{"key":"128_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00005392-200101000-00004","volume":"165","author":"U Jonas","year":"2001","unstructured":"Jonas U, Fowler CJ, Chancellor MB, et al.: Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 2001, 165:15\u201319.","journal-title":"J Urol"},{"key":"128_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0090-4295(96)00506-7","volume":"49","author":"RA Janknegt","year":"1997","unstructured":"Janknegt RA, Weil EH, Eerdmans PH: Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 1997, 49:358\u2013362.","journal-title":"Urology"},{"key":"128_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1097\/01.ju.0000092634.64580.9a","volume":"170","author":"M Spinelli","year":"2003","unstructured":"Spinelli M, Giardiello G, Gerber M, et al.: New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 2003, 170:1905\u20131907.","journal-title":"J Urol"},{"key":"128_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1185\/030079908X253555","volume":"24","author":"TM Kessler","year":"2008","unstructured":"\u2022 Kessler TM, Burkhard FC, Madersbacher H, et al.: Safety of prolonged sacral neuromodulation tined lead testing. Curr Med Res Opin 2008, 24:343\u2013347. The authors address feasibility and patient tolerance of the extended trial period.","journal-title":"Curr Med Res Opin"},{"key":"128_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.eururo.2004.11.005","volume":"47","author":"TM Kessler","year":"2005","unstructured":"Kessler TM, Madersbacher H, Kiss G: Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method? Eur Urol 2005, 47:660\u2013665.","journal-title":"Eur Urol"},{"key":"128_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.ju.0000146480.28680.3e","volume":"173","author":"TM Kessler","year":"2005","unstructured":"Kessler TM, Madersbacher H, Kiss G: Bilateral migration of sacral neuromodulation tined leads in a thin patient. J Urol 2005, 173:153\u2013154.","journal-title":"J Urol"},{"key":"128_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00345-008-0307-7","volume":"26","author":"A Bannowsky","year":"2008","unstructured":"\u2022 Bannowsky A, Wefer B, Braun P, et al.: Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test. World J Urol 2008, 26:623\u2013626. The authors report objective evidence during testing phase showing more robust urodynamic effect with quadripolar tined leads.","journal-title":"World J Urol"},{"key":"128_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.urology.2006.03.020","volume":"68","author":"A Hijaz","year":"2006","unstructured":"Hijaz A, Vasavada SP, Daneshgari F, et al.: Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single institution experience. Urology 2006, 68:533\u2013537.","journal-title":"Urology"},{"key":"128_CR10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1464-410X.2007.07426.x","volume":"101","author":"R Blandon","year":"2008","unstructured":"Blandon R, Gebhart J, Lightner D, et al.: Re-operation rates after permanent sacral nerve stimulation for refractory voiding dysfunction in women. BJU Int 2008, 101:1119\u20131123.","journal-title":"BJU Int"},{"key":"128_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/nau.20332","volume":"26","author":"K Borawski","year":"2007","unstructured":"\u2022\u2022 Borawski K, Foster R, Webster G, et al.: Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women. Neurourol Urodyn 2007, 26:14\u201318. This is a rare prospective randomized trial contrasting the PNE and staged trial techniques.","journal-title":"Neurourol Urodyn"},{"key":"128_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/nau.20345","volume":"26","author":"SE Sutherland","year":"2007","unstructured":"\u2022 Sutherland SE, Lavers A, Carlson A, et al.: Sacral nerve stimulation for voiding dysfunction: one institution\u2019s 11-year experience. Neurourol Urodyn 2007, 26:19\u201328. This article reports a large series of patients from one of the most experienced groups and offers an excellent discussion of neuromodulation.","journal-title":"Neurourol Urodyn"},{"key":"128_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00345-007-0204-5","volume":"25","author":"KD Sievert","year":"2007","unstructured":"Sievert KD, Nagele U, Pannek J, et al.: Subcutaneous tunneling of the temporary testing electrode significantly improving improves the success rate of subchronic sacral nerve modulation (SNM). World J Urol 2007, 25:607\u2013612.","journal-title":"World J Urol"},{"key":"128_CR14","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/S0022-5347(05)64292-9","volume":"168","author":"WA Scheepens","year":"2002","unstructured":"Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE: Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol 2002, 168:2046\u20132050.","journal-title":"J Urol"},{"key":"128_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/nau.20577","volume":"27","author":"K Pham","year":"2008","unstructured":"Pham K, Guralnick ML, O\u2019Connor RC: Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction. Neurourol Urodyn 2008, 27:779\u2013781.","journal-title":"Neurourol Urodyn"},{"key":"128_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00192-007-0466-x","volume":"19","author":"N Zabihi","year":"2008","unstructured":"\u2022 Zabihi N, Mourtzinos A, Maher MG, et al.: Short-term results of bilateral S2\u2013S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct 2008, 19:553\u2013557. These very experienced authors provide the initial description of an alternative method for sacral neuromodulation and early results.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"128_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00192-003-1070-3","volume":"14","author":"KM Peters","year":"2003","unstructured":"Peters KM, Carey JM, Konstandt DB: Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct 2003, 14:223\u2013228.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"128_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.juro.2009.08.142","volume":"183","author":"CR Powell","year":"2010","unstructured":"\u2022\u2022 Powell CR, Kreder KJ: Long-term outcomes of urgency\u2013frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 2010, 183:173\u2013176. This article reports long-term outcomes with an excellent discussion of relevant contemporary literature.","journal-title":"J Urol"},{"key":"128_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.eururo.2003.11.015","volume":"45","author":"K Everaert","year":"2004","unstructured":"Everaert K, Kerckhaert W, Caluwaerts H, et al.: A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol 2004, 45:649\u2013654.","journal-title":"Eur Urol"},{"key":"128_CR20","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.juro.2009.08.031","volume":"182","author":"N Siddiqui","year":"2009","unstructured":"\u2022\u2022 Siddiqui N, Amundsen C, Visco A, et al.: Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol 2009, 182:2799\u20132804. The authors describe their Markov decision model comparing cost-effectiveness of neuromodulation and intravesical botulinum toxin therapy.","journal-title":"J Urol"},{"key":"128_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.urology.2007.07.073","volume":"70","author":"SR Aboseif","year":"2007","unstructured":"Aboseif SR, Kim DH, Rieder JM, et al.: Sacral neuromodulation: cost considerations and clinical benefits. Urology 2007, 70:1069\u20131073.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-010-0128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0128-2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T03:51:42Z","timestamp":1555645902000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-010-0128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1007\/s11934-010-0128-2","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]}}}